Abstract
An improved RP- HPLC method with PDA detection has been developed and validated for the simultaneous estimation of artemisinin and dexamethasone in ocular nanodispersion formulations and it has been successfully adopted to check the ex-vivo corneal transport. The chromatographic separation was achieved using phenomenex C18 column (250 × 4.6 mm, 5 µm) analytical column and the mobile phase consisting of acetonitrile: (methanol : water, 4: 6) mixture at the ratio of 45: 55, v/v at a flow rate of 1.0 mL/min and injection volume of 200 µl. The column temperature was maintained at 50°C. The UV detection was carried out at 219 nm using photodiode array detector. The retention times of dexamethasone and artemisinin were found to be 4.5 and 7.9 minutes respectively. Artemisinin and dexamethasone calibration curves were found to be linear with correlation coefficient of 0.9617 and 0.9954 respectively at a dynamic concentration ranging from 250ng/mL to 1250 ng/mL. Recovery was between the ranges of 98.9% - 116.8% for both artemisinin and dexamethasone. The developed method is very selective as both peaks were well separated with a short analysis time of 10 minutes and does not require any preliminary treatment of sample.
Keywords: Artemisinin, dexamethasone, RP- HPLC, quantification, nanodispersions.
Current Pharmaceutical Analysis
Title:Simultaneous Estimation of Artemisinin and Dexamethasone in Nanodispersions and Assessment of Ex-vivo Corneal Transport Study by RP- HPLC
Volume: 10 Issue: 1
Author(s): Chandrasekar Ponnusamy, Venkateshwaran Krishnaswami, Abimanyu Sugumaran and Subramanian Natesan
Affiliation:
Keywords: Artemisinin, dexamethasone, RP- HPLC, quantification, nanodispersions.
Abstract: An improved RP- HPLC method with PDA detection has been developed and validated for the simultaneous estimation of artemisinin and dexamethasone in ocular nanodispersion formulations and it has been successfully adopted to check the ex-vivo corneal transport. The chromatographic separation was achieved using phenomenex C18 column (250 × 4.6 mm, 5 µm) analytical column and the mobile phase consisting of acetonitrile: (methanol : water, 4: 6) mixture at the ratio of 45: 55, v/v at a flow rate of 1.0 mL/min and injection volume of 200 µl. The column temperature was maintained at 50°C. The UV detection was carried out at 219 nm using photodiode array detector. The retention times of dexamethasone and artemisinin were found to be 4.5 and 7.9 minutes respectively. Artemisinin and dexamethasone calibration curves were found to be linear with correlation coefficient of 0.9617 and 0.9954 respectively at a dynamic concentration ranging from 250ng/mL to 1250 ng/mL. Recovery was between the ranges of 98.9% - 116.8% for both artemisinin and dexamethasone. The developed method is very selective as both peaks were well separated with a short analysis time of 10 minutes and does not require any preliminary treatment of sample.
Export Options
About this article
Cite this article as:
Ponnusamy Chandrasekar, Krishnaswami Venkateshwaran, Sugumaran Abimanyu and Natesan Subramanian, Simultaneous Estimation of Artemisinin and Dexamethasone in Nanodispersions and Assessment of Ex-vivo Corneal Transport Study by RP- HPLC, Current Pharmaceutical Analysis 2014; 10 (1) . https://dx.doi.org/10.2174/157341291001140102111031
DOI https://dx.doi.org/10.2174/157341291001140102111031 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Disorders of Sex Development: A Review
Current Women`s Health Reviews Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition
Current Drug Delivery Applications of Nanosystems to Anticancer Drug Therapy (Part I. Nanogels, Nanospheres, Nanocapsules)
Recent Patents on Anti-Cancer Drug Discovery Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer
Current Drug Metabolism Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma
Current Radiopharmaceuticals Ovarian Cancer - Angiogenesis and Targeted Therapy
Current Angiogenesis (Discontinued) IP6 & Inositol in Cancer Prevention and Therapy
Current Cancer Therapy Reviews Synthesis and in vitro Anti-tumor Activity of Some New Sebacoyl Chloride Based Heterocycles
Current Organic Synthesis Small-Molecule Inhibitors Targeting eIF4A in Leukemia
Current Protein & Peptide Science Modulation of pRb/E2F Functions in the Regulation of Cell Cycle and in Cancer
Current Cancer Drug Targets Targeted Angiogenesis Therapy in Head and Neck Squamous Cell Carcinomas
Current Angiogenesis (Discontinued) Probiotics in the Prevention of Urogenital Tract Infections. Mechanisms Involved
Current Women`s Health Reviews The Development of Copper Radiopharmaceuticals for Imaging and Therapy
Medicinal Chemistry Co-delivery Strategies Based on Multifunctional Nanocarriers for Cancer Therapy
Current Drug Metabolism The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
Current Medicinal Chemistry Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives
Anti-Cancer Agents in Medicinal Chemistry Phenylbutyrate is a Multifaceted Drug that Exerts Neuroprotective Effects and Reverses the Alzheimer´s Disease-like Phenotype of a Commonly Used Mouse Model
Current Pharmaceutical Design Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics Bacterial Zinc Proteases and their Inhibition
Current Enzyme Inhibition Editorial
Reviews on Recent Clinical Trials